
DO WE USE METHYLATION OF NFATC1 AND FOS GENES AS
A BIOMARKER FOR POSTMENOPAUSAL OSTEOPOROSIS? Kalkan R, Tosun O *Corresponding Author: Associate Professor Rasime Kalkan, Department of Medical Genetics, Faculty
of Medicine, Near East University, Near East Boulevard, Nicosia, Cyprus, 99138. Tel: +903-92-
223-6464. Fax: +903-92-223-6461. E-mail: rasime.kalkan@neu.edu.tr, kalkanr@yahoo.com page: 35
|
RESULTS
The mean age of 30 premenopause patients was 33.5
± 6.9 years and the mean age of 35 postmenopause patients
was 56.7 ± 4.9 years. There were no significant differences
between the premenopausal and postmenopausal group in
bone mineral density (BMD) (p >0.005).
The NFATC1 promotor methylation was detected in
11 of the 35 postmenopausal women (31.4%) (Figure 1)
and unmethylated in 24 of the 35 postmenopausal women
(68.8%). The NFATC1 promotor methylation was detected
in 19 of the 30 (63.3%) control sample (premenopausal
women) and unmethylated in 11 of the 30 control sample
(36.7%). Here, we found statistically significant correlation
between postmenopause and unmethylation of NFATC1
promotor (p = 0.010).
The FOS promotor methylation was detected in six
of the 35 (17.1%) postmenopausal women (Figure 2) and
unmethylated in 29 of the 35 postmenopausal women
(82.9%) (p >0.005). The FOS promotor methylation was
detected in five of the 30 (16.7%) control sample (premenopausal
women) and unmethylated in 25 of the 30
control sample (83.3%). Moreover, there was no statistically
significant association identified between menopause
and methylation status (p >0.05) (Table 1).
|
|
|
|



 |
Number 27 VOL. 27 (2), 2024 |
Number 27 VOL. 27 (1), 2024 |
Number 26 Number 26 VOL. 26(2), 2023 All in one |
Number 26 VOL. 26(2), 2023 |
Number 26 VOL. 26, 2023 Supplement |
Number 26 VOL. 26(1), 2023 |
Number 25 VOL. 25(2), 2022 |
Number 25 VOL. 25 (1), 2022 |
Number 24 VOL. 24(2), 2021 |
Number 24 VOL. 24(1), 2021 |
Number 23 VOL. 23(2), 2020 |
Number 22 VOL. 22(2), 2019 |
Number 22 VOL. 22(1), 2019 |
Number 22 VOL. 22, 2019 Supplement |
Number 21 VOL. 21(2), 2018 |
Number 21 VOL. 21 (1), 2018 |
Number 21 VOL. 21, 2018 Supplement |
Number 20 VOL. 20 (2), 2017 |
Number 20 VOL. 20 (1), 2017 |
Number 19 VOL. 19 (2), 2016 |
Number 19 VOL. 19 (1), 2016 |
Number 18 VOL. 18 (2), 2015 |
Number 18 VOL. 18 (1), 2015 |
Number 17 VOL. 17 (2), 2014 |
Number 17 VOL. 17 (1), 2014 |
Number 16 VOL. 16 (2), 2013 |
Number 16 VOL. 16 (1), 2013 |
Number 15 VOL. 15 (2), 2012 |
Number 15 VOL. 15, 2012 Supplement |
Number 15 Vol. 15 (1), 2012 |
Number 14 14 - Vol. 14 (2), 2011 |
Number 14 The 9th Balkan Congress of Medical Genetics |
Number 14 14 - Vol. 14 (1), 2011 |
Number 13 Vol. 13 (2), 2010 |
Number 13 Vol.13 (1), 2010 |
Number 12 Vol.12 (2), 2009 |
Number 12 Vol.12 (1), 2009 |
Number 11 Vol.11 (2),2008 |
Number 11 Vol.11 (1),2008 |
Number 10 Vol.10 (2), 2007 |
Number 10 10 (1),2007 |
Number 9 1&2, 2006 |
Number 9 3&4, 2006 |
Number 8 1&2, 2005 |
Number 8 3&4, 2004 |
Number 7 1&2, 2004 |
Number 6 3&4, 2003 |
Number 6 1&2, 2003 |
Number 5 3&4, 2002 |
Number 5 1&2, 2002 |
Number 4 Vol.3 (4), 2000 |
Number 4 Vol.2 (4), 1999 |
Number 4 Vol.1 (4), 1998 |
Number 4 3&4, 2001 |
Number 4 1&2, 2001 |
Number 3 Vol.3 (3), 2000 |
Number 3 Vol.2 (3), 1999 |
Number 3 Vol.1 (3), 1998 |
Number 2 Vol.3(2), 2000 |
Number 2 Vol.1 (2), 1998 |
Number 2 Vol.2 (2), 1999 |
Number 1 Vol.3 (1), 2000 |
Number 1 Vol.2 (1), 1999 |
Number 1 Vol.1 (1), 1998 |
|
|